Engel AG. Late-onset rod myopathy (a new syndrome?): light and electron microscopic observations in two cases. Mayo Clin Proc. 1966;41(11):713–41.
Schnitzler LJ, Schreckenbach T, Nadaj-Pakleza A, Stenzel W, Rushing EJ, Van Damme P, et al. Sporadic late-onset nemaline myopathy: clinico-pathological characteristics and review of 76 cases. Orphanet J Rare Dis. 2017;12(1):86. https://doi.org/10.1186/s13023-017-0640-2.
Article PubMed PubMed Central Google Scholar
Chahin N, Selcen D, Engel AG. Sporadic late onset nemaline myopathy. Neurology. 2005;65(8):1158–64. https://doi.org/10.1212/01.wnl.0000180362.90078.dc.
Dalakas MC, Pezeshkpour GH, Flaherty M. Progressive nemaline (rod) myopathy associated with HIV infection. N Engl J Med. 1987;317(25):1602–3. https://doi.org/10.1056/NEJM198712173172511.
Article CAS PubMed Google Scholar
Naddaf E, Milone M, Kansagra A, Buadi F, Kourelis T. Sporadic late-onset nemaline myopathy: clinical spectrum, survival, and treatment outcomes. Neurology. 2019;93(3):e298–305. https://doi.org/10.1212/WNL.0000000000007777.
De Ridder W, De Jonghe P, Straub V, Baets J. High prevalence of sporadic late-onset nemaline myopathy in a cohort of whole-exome sequencing negative myopathy patients. Neuromuscul Disord. 2021;31(11):1154–60. https://doi.org/10.1016/j.nmd.2021.04.010. This study highlights the possible chronic course of SLONM, mimicking muscular dystrophy.
Monforte M, Primiano G, Silvestri G, Mirabella M, Luigetti M, Cuccagna C, et al. Sporadic late-onset nemaline myopathy: clinical, pathology and imaging findings in a single center cohort. J Neurol. 2018;265(3):542–51. https://doi.org/10.1007/s00415-018-8741-y.
Tanboon J, Uruha A, Arahata Y, Dittmayer C, Schweizer L, Goebel HH, et al. Inflammatory features in sporadic late-onset nemaline myopathy are independent from monoclonal gammopathy. Brain Pathol. 2021;31(3):e12962. https://doi.org/10.1111/bpa.12962. This study describes a mild inflammatory reaction in muscle samples of SLONM patients, occurring independently from the presence of monoclonal gammopathy and supporting possible immune pathogenesis as well as use of immunotherapy for SLONM treatment.
Zhao B, Dai T, Zhao D, Ma X, Zhao C, Li L, et al. Clinicopathologic profiles of sporadic late-onset nemaline myopathy: practical importance of anti-alpha-actinin immunostaining. Neurol Neuroimmunol Neuroinflamm. 2022;9(4). https://doi.org/10.1212/NXI.0000000000001184. This study underscores how immunostaining for alpha-actinin enables the easy visualization of nemaline rods for diagnosis of SLONM.
Kotchetkov R, Susman D, Bhutani D, Broch K, Dispenzieri A, Buadi FK. Chemotherapy-based approach is the preferred treatment for sporadic late-onset nemaline myopathy with a monoclonal protein. Int J Cancer. 2021;148(11):2807–14. https://doi.org/10.1002/ijc.33483. This study discusses the treatment of SLONM with chemotherapy and HSCT from a hemathological prospective.
Kemta Lekpa F, Chevalier X, Dubourg O, Dimitri D. Isolated camptocormia revealing sporadic late onset nemaline myopathy. Presse Med. 2013;42(7–8):1142–4. https://doi.org/10.1016/j.lpm.2012.11.007.
Nakamura K, Shibuya K, Nishino I, Kuwabara S. Dropped head in sporadic late-onset nemaline myopathy. Intern Med. 2019;58(13):1967–8. https://doi.org/10.2169/internalmedicine.2247-18.
Article PubMed PubMed Central Google Scholar
Turk M, Nagel AM, Roemer F, Schlotzer-Schrehardt U, Thiel CT, Winterholler M, et al. Camptocormia as the presenting symptom in sporadic late onset nemaline myopathy: a case report. BMC Musculoskelet Disord. 2019;20(1):553. https://doi.org/10.1186/s12891-019-2942-0.
Article PubMed PubMed Central Google Scholar
Alhammad RM, Naddaf E. Myopathies presenting with head drop: clinical spectrum and treatment outcomes. Neuromuscul Disord. 2020;30(2):128–36. https://doi.org/10.1016/j.nmd.2019.12.001.
Wengert O, Meisel A, Kress W, Dekomien G, Angstwurm K, Heppner FL, et al. Progressive external ophthalmoplegia as initial manifestation of sporadic late-onset nemaline myopathy. J Neurol. 2011;258(5):915–7. https://doi.org/10.1007/s00415-010-5819-6.
Kirupaharan P, Kramer D, Gandler A, Kenyon L, Summer R. 68-year old man with progressive weakness and ventilator dependent respiratory failure: a case report of sporadic late onset nemaline myopathy. BMC Pulm Med. 2022;22(1):97. https://doi.org/10.1186/s12890-022-01877-4.
Article PubMed PubMed Central Google Scholar
Belhomme N, Maamar A, Le Gallou T, Minot-Myhie MC, Larralde A, Champtiaux N, et al. Rare myopathy associated to MGUS, causing heart failure and responding to chemotherapy. Ann Hematol. 2017;96(4):695–6. https://doi.org/10.1007/s00277-016-2916-3.
Turnquist C, Grogono JC, Hofer M, Pitcher A. Sporadic late-onset nemaline myopathy: a case report of a treatable cause of cardiac failure. Eur Heart J Case Rep. 2021;5(1):ytaa480. https://doi.org/10.1093/ehjcr/ytaa480.
Jones JG, Factor SM. Familial congestive cardiomyopathy with nemaline rods in heart and skeletal muscle. Virchows Arch A Pathol Anat Histopathol. 1985;408(2–3):307–12. https://doi.org/10.1007/BF00707993.
Article CAS PubMed Google Scholar
Nandy A, Tankisi H, Kroigard AB, Dalager MG, Hvidbjerg MS, Schroder HD, et al. Sporadic late onset nemaline myopathy with concurrent dermatological symptoms responding to immunosuppressive treatment. BMC Neurol. 2023;23(1):233. https://doi.org/10.1186/s12883-023-03283-7.
Article CAS PubMed PubMed Central Google Scholar
Bos MM, Overeem S, van Engelen BG, Scheffer H, van den Elzen C, Ter Laak H, et al. A case of neuromuscular mimicry. Neuromuscul Disord. 2006;16(8):510–3. https://doi.org/10.1016/j.nmd.2006.06.005.
Dimitri D, Dubourg O. Sporadic late-onset nemaline myopathy in a patient with systemic lupus erythematosus. J Neurol. 2013;260(12):3171–3. https://doi.org/10.1007/s00415-013-7168-8.
Vogel C, Manwani P, Cornford ME, Heinze ER. Nemaline myopathy in newly diagnosed systemic lupus erythematosus and Sjogren’s overlap syndrome complicated by macrophage activation syndrome. BMC Rheumatol. 2022;6(1):21. https://doi.org/10.1186/s41927-022-00246-2.
Article PubMed PubMed Central Google Scholar
Cao L, Wang Y, Liu X, Hu Y, Li N, Qiu G, et al. Adult-onset nemaline myopathy coexisting with myasthenia gravis: a case report. Medicine (Baltimore). 2016;95(4):e2527. https://doi.org/10.1097/MD.0000000000002527.
Milone M, Katz A, Amato AA, Soderland CA, Segarceanu M, Young NP, et al. Sporadic late onset nemaline myopathy responsive to IVIg and immunotherapy. Muscle Nerve. 2010;41(2):272–6. https://doi.org/10.1002/mus.21504.
Paramalingam S, Dyke JM, Nossent JC. Sporadic late onset nemaline myopathy (SLONM) in an adult presenting with progressive muscle weakness. Eur J Rheumatol. 2019;6(2):105–7. https://doi.org/10.5152/eurjrheum.2018.18071.
Montagnese F, Portaro S, Musumeci O, Migliorato A, Moggio M, Fagiolari G, et al. Sporadic late-onset nemaline myopathy in a woman with multiple myeloma successfully treated with lenalidomide/dexamethasone. Muscle Nerve. 2015;51(6):934–5. https://doi.org/10.1002/mus.24545.
Article CAS PubMed Google Scholar
Sewry CA, Laitila JM, Wallgren-Pettersson C. Nemaline myopathies: a current view. J Muscle Res Cell Motil. 2019;40(2):111–26. https://doi.org/10.1007/s10974-019-09519-9.
Article CAS PubMed PubMed Central Google Scholar
Nicolau S, Liewluck T, Tracy JA, Laughlin RS, Milone M. Congenital myopathies in the adult neuromuscular clinic: diagnostic challenges and pitfalls. Neurol Genet. 2019;5(4):e341. https://doi.org/10.1212/NXG.0000000000000341.
Article CAS PubMed PubMed Central Google Scholar
Maeda MH, Ohta H, Izutsu K, Shimizu J, Uesaka Y. Sporadic late-onset nemaline myopathy as a rare cause of slowly progressive muscle weakness with young adult onset. Muscle Nerve. 2015;51(5):772–4. https://doi.org/10.1002/mus.24509.
Kyle RA, Therneau TM, Rajkumar SV, Larson DR, Plevak MF, Offord JR, et al. Prevalence of monoclonal gammopathy of undetermined significance. N Engl J Med. 2006;354(13):1362–9. https://doi.org/10.1056/NEJMoa054494.
Article CAS PubMed Google Scholar
Nicolau S, Dasgupta A, Dasari S, Charlesworth MC, Johnson KL, Pandey A, et al. Molecular signatures of inherited and acquired sporadic late onset nemaline myopathies. Acta Neuropathol Commun. 2023;11(1):20. https://doi.org/10.1186/s40478-023-01518-9. This study employed a combination of muscle morphology, transcriptomics, and proteomics to investigate the morphological and pathophysiological differences between SLONM and iNM.
Naddaf E, Dasari S, Selcen D, Charlesworth MC, Johnson KL, Mauermann ML, et al. Proteomic profiling of sporadic late-onset nemaline myopathy. Ann Clin Transl Neurol. 2022;9(3):391–402. https://doi.org/10.1002/acn3.51527.
Article CAS PubMed PubMed Central Google Scholar
Doppler K, Knop S, Einsele H, Sommer C, Wessig C. Sporadic late onset nemaline myopathy and immunoglobulin deposition disease. Muscle Nerve. 2013;48(6):983–8. https://doi.org/10.1002/mus.23954.
Eymard B, Brouet JC, Collin H, Chevallay M, Bussel A, Fardeau M. Late-onset rod myopathy associated with monoclonal gammopathy. Neuromuscul Disord. 1993;3(5–6):557–60. https://doi.org/10.1016/0960-8966(93)90115-z.
Article CAS PubMed Google Scholar
Wang M, Lei L, Chen H, Di L, Pang M, Lu Y, et al. Monoclonal gammopathy with both nemaline myopathy and amyloid myopathy. Neuromuscul Disord. 2017;27(10):942–6. https://doi.org/10.1016/j.nmd.2017.05.007.
Moshe-Lilie O, Banks G, Medvedova E, Masri A, Chahin N. Coexisting sporadic late onset nemaline myopathy and AL amyloid myopathy - incidental or related? Neuromuscul Disord. 2022;32(6):533–8. https://doi.org/10.1016/j.nmd.2022.03.006.
Uruha A, Benveniste O. Sporadic late-onset nemaline myopathy with monoclonal gammopathy of undetermined significance. Curr Opin Neurol. 2017;30(5):457–63. https://do
Comments (0)